Choe B K, Lillehoj H S, Dong M K, Gleason S, Barron M, Rose N R
Ann N Y Acad Sci. 1982;390:16-26. doi: 10.1111/j.1749-6632.1982.tb40301.x.
Human prostatic acid phosphatase [PAP] is antigenically uniquely different from acid phosphatases of other tissue origins. Nevertheless, a small degree of antigenic cross-reactivity between PAP and other lysosomal acid phosphatase(s) [LAP] has been suspected. In order to resolve this question, we have adopted two approaches: one involving structural studies by peptide mapping, and the other involving topological mapping through the use of uniquely defined antibodies. Purified PAP was dissociated into subunits and was further cleaved by chemical and enzymological methods. The limited digestion of PAP by submaxillary protease yielded three fragments [Sp-1, 2, and 3]. One of the fragments, Sp-3 [Mr = 11,000-12,000], was shown to regain catalytic activity after interaction with anti-PAP antibodies. This along with other data suggested that the active site is localized in the Sp-3 fragment. These submaxillary protease fragments were also used in the antigenic studies. For the detailed antigenic mapping studies, we prepared 12 monoclonal anti-PAP antibodies. These monoclonal anti-PAP antibodies exhibited a remarkably specific binding to PAP, particularly to the Sp-1 fragment, without binding to other acid phosphatase preparations. We also prepared lysosomal acid phosphatase [LAP] and raised anti-LAP antibodies in rabbits. The anti-LAP antibodies were fractionated into subpopulations by the preparative isoelectric focusing method. Three anti-LAP antibody subpopulations [pI 5.2, 6.9, and 7.5] exhibited specific binding to LAP. However, two anti-LAP subpopulations [pI 5.3 and and 6.8] showed binding to the Sp-3 fragment, an active site fragment of PAP. Thus, the PAP molecule seems to consist of three domains, namely, Sp-1, Sp-3, and Sp-2. Sp-3, which is the active site domain, is an antigenically cross-reactive region. The Sp-1 domain represents an antigenically unique region of PAP, whereas none of the antibodies studied thus far bind to the Sp-2 fragment.
人前列腺酸性磷酸酶[PAP]在抗原性上与其他组织来源的酸性磷酸酶有独特差异。然而,有人怀疑PAP与其他溶酶体酸性磷酸酶[LAP]之间存在一定程度的抗原交叉反应。为了解决这个问题,我们采用了两种方法:一种是通过肽图谱进行结构研究,另一种是通过使用独特定义的抗体进行拓扑图谱研究。纯化的PAP被解离成亚基,并通过化学和酶学方法进一步切割。下颌下蛋白酶对PAP的有限消化产生了三个片段[Sp-1、2和3]。其中一个片段Sp-3[Mr = 11,000 - 12,000]在与抗PAP抗体相互作用后显示恢复催化活性。这与其他数据表明活性位点位于Sp-3片段中。这些下颌下蛋白酶片段也用于抗原研究。为了进行详细的抗原图谱研究,我们制备了12种单克隆抗PAP抗体。这些单克隆抗PAP抗体与PAP表现出显著的特异性结合,特别是与Sp-1片段结合,而不与其他酸性磷酸酶制剂结合。我们还制备了溶酶体酸性磷酸酶[LAP]并在兔中产生抗LAP抗体。抗LAP抗体通过制备性等电聚焦方法分离成亚群。三个抗LAP抗体亚群[pI 5.2、6.9和7.5]与LAP表现出特异性结合。然而,两个抗LAP亚群[pI 5.3和6.8]显示与Sp-3片段结合,Sp-3片段是PAP的活性位点片段。因此,PAP分子似乎由三个结构域组成,即Sp-1、Sp-3和Sp-2。Sp-3是活性位点结构域,是一个抗原交叉反应区域。Sp-1结构域代表PAP的抗原独特区域,而迄今为止研究的抗体均不与Sp-2片段结合。